Medical Wire's new Sigma-Virocult® range has played a vital role throughout the recent and current Novel H1N1 influenza pandemic. As vaccines start to become available it remains vital to monitor which strains are still circulating in the population. And as winter takes hold in the northern hemisphere, all the other respiratory viruses will require surveillance.

Sigma-Virocult® offers the advantage of being compatible with the modern rapid diagnostic tests, while allowing the maintenance of viable virus for culture for complete characterisation, and the detection of novel strains for which rapid methods have not been developed.